CDK2 and lung cancer: In summary, our study demonstrates a mechanism by which CBX4 enhances the proliferation and metastasis of lung cancer in vitro via up‐regulating the expression of BMI‐1, thereby increasing the expression and activity of P53, CDK2, Cyclin E, MMP2, MMP9 and CXCR4.